MedPath

To compare postoperative analgesic efficacy after infiltrating Bupivacaine with Dexmedetomidine vs Bupivacaine alone at surgical incision site in below umbilical surgeries.

Phase 4
Not yet recruiting
Registration Number
CTRI/2025/06/088250
Lead Sponsor
Dr Punit kumar
Brief Summary

This study is a prospective, interventional, randomized comparison of the postoperative analgesic effect of bupivacaine with dexmedetomidine versus bupivacaine alone for local infiltration at the surgical incision site in infraumbilical surgeries. A total of 148 patients aged 18 to 50 years undergoing infraumbilical surgeries were randomly divided into two groups. Group DB received 20 mL of 0.25 percent bupivacaine with 50 mcg dexmedetomidine, and Group PB received 20 mL of 0.25 percent bupivacaine with 0.5 mL normal saline. The study assessed duration of analgesia, total rescue analgesic requirement in 24 hours, VAS pain scores, and hemodynamic changes. Pain was measured using the Visual Analogue Scale at regular intervals and rescue analgesia was administered if the VAS score was 4 or more. Hemodynamic parameters were monitored, and data were analyzed using standard statistical methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
148
Inclusion Criteria
  • 1.Patients giving informed consent to participate in the study.
  • 2.All patients posted for below umbilicus surgeries.
  • 3.Age of the patient between 18-50 years.
  • 4.Patients belonging to ASA I & ASA II.
Exclusion Criteria
  • 1.Patients with morbid obesity 2.Patients with Raynaud’s disease 3.Patients belonging to ASA class III and IV.
  • 4.Patients with co morbidities 5.Patients with infection at the site of infiltration.
  • 6.Patients with psychiatric disorders.
  • 7.Patients with history of hypersensitivity to any of the drugs under study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To estimate the duration of postoperative analgesia after local infiltration in both groups, Bupivacaine alone and Bupivacaine mixed with Dexmedetomidineat 5 minutes, 30 minutes, 45 minutes, 75 minutes, 90 minutes, 2hour, 4 hour, 6 hour, 12 hour, 24 hour
Secondary Outcome Measures
NameTimeMethod
To calculate the total amount of rescue analgesic consumed in 24 hoursat 3 hour, 6 hour, 12 hour, 24 hour
To observe VAS score after infiltrationat 5 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 2 hour, 4 hour, 6 hour, 12 hour, 24 hour
To observe the hemodynamic changes after local infiltration of Dexmedetomidine added to Bupivacaine at incision siteat 15 minutes, 30 minutes, 45 minutes, 60 minutes, 3 hour, 6 hour, 9 hour, 12 hour, 16 hour, 20 hour, 24 hour

Trial Locations

Locations (1)

Susheela tiwari government hospital

🇮🇳

Nainital, UTTARANCHAL, India

Susheela tiwari government hospital
🇮🇳Nainital, UTTARANCHAL, India
Dr Punit Kumar
Principal investigator
9759889895
drpuneetk007@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.